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ABSTRACT 
 
Background: 
Obesity is a state of excess adipose tissue mass abdominal obesity or central obesity 
occurs when excessive abdominal fat around the stomach and abdomen there is a 
strong correlation between central obesity and cardiovascular disease. Obesity is 
associated with the development of some of the most prevalent diseases of modern 
society such as Type-II Diabetes Mellitus, hypertension, coronary artery disease, 
certain forms of cancer, arthritis, renal failure and gall bladder disease, and is 
associated with high morbidity and mortality. 
Generalized obesity measured by Body Mass Index (BMI) is one of the major causes 
of ill health in the society. However, abdominal obesity, which is closely associated 
with intra-abdominal fat and measured either by waist circumference or waist-to-hip 
ratio, predicts subsequent coronary artery disease. 
Aim:  
This study was planned to evaulate the effect of Bhastrika pranayama on abdominal 
obesity. 
Methods: Sixty [male or female] patients with Abdominal Obesity of age group 
between 18-45 years will participate in the study. After obtaining informed consent, 
they will be subjected to be measured for their Height, Weight, BMI, Hip and Waist 
Circumference and Waist-Hip ratio and Abdominal skin fold thickness. 
 XII 
 
After obtaining informed consent, the selected   patients would be subjected to Yoga 
Therapy for 10 mintues/twice a day for 60 days, under the supervision of Department 
of Yoga and Naturopathy, Government Yoga and Naturopathy Medical College, 
Arumbakkam, Chennai 106.    
Results:  
Based on the analysis of the results obtained, we can conclude the differences were 
found in weight, BMI, Skin fold thickness between study group and control group. 
Keywords: Bhastrika Pranayama, BMI, Waist hip Ratio, Skin Fold Thickness, Body 
Mass Index, Abdominal Obesity 
Interpretation and conclusion: Two months combined practice of Bhastrika Pranayama 
in obese individuals showed minimal changes in Waist Hip Ratio and BMI. 
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1.0 INTRODUCTION 
 
Obesity condition usually translates into excessive body weight. On the one hand obesity 
can develop even in the absence of excessive body weight, whereas on the other hand a 
person (eg, a body builder) can develop remarkable overweight without excessive body 
fatness. 
Interestingly, the word “obesity” (from the Latin obesitas) used today in a purely 
descriptive way, in its etimology, points to the most common behavioral condition 
leading to obesity, ie overeating. In fact, obesitas is the condition of the obesus (ie, 
plump), word that, in turn, is composed of ob (ie, over) and esus, i.e., the past participle 
of edere (ie, to eat). 
Obesity can be classified in several different ways: for example, by BMI intervals and 
related aggregate risk of mortality, by anatomic phenotypes or by etiologic criteria. 
According to the World Health Organization (WHO), obesity is classified as class I for 
a BMI between 30 and 34.9 kg/m2, class II for a BMI between 35 and 39.9 kg/m2, and 
class III for a BMI ≥ 40 kg/m2 1. In turn, class I obesity is associated with (hence, labeled 
as) a “moderate risk”, class II with a “high risk”, and class III with a “very high risk” of 
mortality2. The most common anatomical characterization refers to a prevalently visceral 
or a prevalently subcutaneous deposition of fat. The ratio of waist circumference to hip 
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circumference (WHR) has served the purpose of defining the degree of central (i.e., 
visceral) vs. peripheral (i.e., subcutaneous) obesity.  
Obesity recognized excess accumulation of fats (Resulting in increased weight). Obesity 
is most commonly caused by a combination of excessive food intake, lack of physical 
activity, and genetic susceptibility. The prevalence of obesity worldwide is rising caused 
primarily by genes, endocrine disorders, medications. One important category of obesity 
not captured by BMI is so-called “abdominal obesity”-the extra fat found around the 
middle that is an important factor in health, even independent of BMI.  
Abdominal obesity is known that visceral adiposity is a major risk factor for metabolic 
complications of obesity, while subcutaneous fat seems to be much more benign, and in 
some cases even protective against the development of metabolic complications. Waist–
hip ratio was suggested as an additional measure of body fat distribution1,26 . In women, 
BMI was associated with increased risk of systemic diseases; however, waist–hip ratio 
appeared to be a stronger independent risk factor than BMI.2 The simplest and most often 
used measure of abdominal obesity is waist size. Guidelines generally define abdominal 
obesity in women as a waist size 35 inches or higher, and in men as a waist size of 40 
inches or higher. There are a number of ways to measure body fat. Globally, there are 
1.5 billion adults who are either overweight or obese, a number expected to increase to 
3 billion by 2030. Obesity in India has reached epidemic proportions in the 21st century, 
with morbid obesity affecting 5% of the country's population. India is following a trend 
of other developing countries that are steadily becoming more obese. Obesity is a major 
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risk factor for cardiovascular disease metabolic disorders3. In addition to inadequate 
eating habits, a sedentary lifestyle is the main cause of obesity4. The point prevalence is 
higher in women (15%) than in men (11%)5. Management of obesity can include lifestyle 
changes, medications, or surgery. The main treatment for obesity consists 
of dieting and Yoga. Yoga has an important role to play in the treatment of Obesity. 
Yoga techniques affect body, internal organs, endocrine glands, brain, mind and other 
factors concerning Body-Mind complex. Various Yoga techniques can be practiced 
effectively to reduce the weight and achieve normal healthy condition of Body and Mind. 
Yoga is a means of balancing and harmonizing the body, mind and emotions. From the 
physical body, yoga moves on to the mental and emotional levels. Yoga is simply a 
means of maintaining health and well-being in an increasingly stressful society6. 
Studies have shown that BMI is a reasonable measure of adiposity given that body 
weight and stature are simple, inexpensive, safe, and practical measurements to acquire7-
12. Several population studies suggest that overall BMI increases with age up to the fifth 
or sixth decade after which BMI declines13. The results of the study on “How Useful Is 
Body Mass Index for Comparison of Body Fatness across Age, Sex, and Ethnic 
Groups?” demonstrate a strong influence of age and sex, but not of ethnicity, on the 
relation between BMI and body fatness. These findings should be considered when 
interpreting BMI results in population studies and when designing clinical trials in which 
body fatness is a main study variable14. 
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Management of obesity can include lifestyle changes, medications, or surgery. The main 
treatment for obesity consists of dieting and Yoga. Yoga has an important role to play in 
the treatment of Obesity. Yoga techniques affect body, internal organs, endocrine glands, 
brain, mind and other factors concerning Body-Mind complex. Various Yoga techniques 
can be practiced effectively to reduce the weight and achieve normal healthy condition 
of Body and Mind. Yoga is a means of balancing and harmonizing the body, mind and 
emotions. From the physical body, yoga moves on to the mental and emotional levels. 
Yoga is simply a means of maintaining health and well-being in an increasingly stressful 
society.  
The National Centre for Complementary and Alternative Medicine (NCCAM) refers to 
yoga as a ―mind-body medicine, with its use being recommended as a non-
pharmacological tool for managing various non-communicable diseases. Yoga which 
includes various postures (Asanas), breathing techniques (Pranayama), and meditation18 
has been shown to have therapeutic benefits for individuals with a wide range of health 
conditions. 
Generalized obesity measured by body mass index (BMI) is one of the major causes of 
ill health in the society. However, abdominal obesity, which is closely associated with 
intraabdominal fat and measured either by waist circumference or waist-to-hip ratio, 
predicts subsequent coronary artery disease15.  
Obesity is associated with the development of some of the most prevalent diseases of 
modern society, such as Type-II Diabetes Mellitus, hypertension, coronary artery 
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disease, certain forms of cancer, arthritis, renal failure and gall bladder disease, and is 
associated with high morbidity and mortality16. 
In a study conducted on the “Effect of Bhastrika pranayama on waist and hip 
circumference” in the study group, the waist circumference and hip circumference 
decreased significantly as compared to that of control group. This shows that Bhastrika 
pranayama has reducing impact on waist circumference and hip circumference in 
overweight individuals17.  
 In a study conducted on “Yoga in Women With Abdominal Obesity— a Randomized 
Controlled Trial”, an intensive yoga intervention lasting 8 weeks including women with 
abdominal obesity reduced participants’ waist circumference, waist-hip ratio, body 
weight, BMI, and percentage of body fat and increased the percentage of muscle mass. 
Yoga improved participants’ mental and physical wellbeing and self esteem, and reduced 
their perceived stress18.  
 In a study conducted on “Effect of Bhastrika on selected body composition variables” 
the results showed significant effect on body fat % and no change was found in control 
group19.  
In a study conducted on “Effect of yogic asana on body mass index” Yoga group showed 
a significant improvement after 8 weeks of yogic posture in body mass index20. A study 
conducted on the “Effect of Yoga and various Asanas on Obesity, Hypertension & 
Dyslipidemia” showed significant decrease in the parameters of obesity viz. BMI and 
WHR, significant improvement in hypertension both systolic and diastolic blood 
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pressure and significant improvement in various lipid profile parameters viz. decrease in 
total cholesterol, LDL, triglycerides, VLDL and increase in HDL in study group as 
compared to control group21. The study on “Effect of Yoga on Heart Rate, Blood 
Pressure, Body Mass Index” showed that there was a significant reduction in blood 
pressure, heart rate, and BMI in the total cohort with yoga. SBP, HR and BMI value 
shows statistically highly significant (p<0.05)22. 
The study on “Effects of Yogic practices on Body Mass Index and Body Fat among 
Obese Women”, BMI (p<0.05) and percentage of body fat (p<0.05) were significantly 
decreased in yoga group than the control group. Regular yogic practices resulted 
beneficial health improvement in obese women by decreasing BMI and percentage of 
body fat23.  The “Effect of Pranayama on Body Mass Index in Young Medical Students” 
concluded that Short term pranayama have reducing impact on BMI and also have 
positive and useful effect on weight reduction in young adults24.  Study on “Effect of 
Bhastrika Pranayama on Body Mass Index and Abdominal Skin fold Thickness” Showed 
that body mass index and abdominal skin fold thickness is decreased in the subjects from 
study group as compared to that of control group at the end of 8 weeks25.  Although the 
above mentioned studies reveal the efficacy of various pranayamas on Abdominal 
Obesity, this study implies the effect of Bhastrika Pranayama on Abdominal Obesity.    
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2.0 AIMS AND OBJECTIVES 
2.1 Aim  
The aim of this study was to assess the effect of Bastrika pranayama changes in the 
Abdominal obesity in men and women. 
2.2 Objectives of the study   
The objectives of the present study are:  
 To record the BMI, Skin Fold Thickness (SFT)  and Waist-Hip ratio before and 
after intervention  
 To record the Resting Cardio-respiratory parameters before and after intervention 
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3.0 REVIEW OF LITERATURE 
3.1 Obesity 
Obesity is a medical condition in which excess body fat has accumulated to the extent 
that it may have a negative effect on health. Obesity is a leading preventable cause of 
death worldwide, with increasing rates among adults and children.  
3.2 Causes of Obesity 
The balance between calorie intake and energy expenditure determines a person's 
weight. If a person eats more calories than he or she burns (metabolizes), the person 
gains weight (the body will store the excess energy as fat). If a person eats fewer calories 
than he or she metabolizes, he or she will lose weight. Therefore the most common 
causes of obesity are overeating and physical inactivity. Ultimately, body weight is the 
result of genetics, metabolism, environment, behavior, and culture. 
3.2.1 Genetics 
A person is more likely to develop obesity if one or both parents are obese. Genetics also 
affect hormones involved in fat regulation. For example, one genetic cause of obesity is 
leptin deficiency. Leptin is a hormone produced in fat cells and also in the placenta. 
Leptin controls weight by signaling the brain to eat less when body fat stores are too 
high. If, for some reason, the body cannot produce enough leptin or leptin cannot signal 
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the brain to eat less, this control is lost, and obesity occurs. The role of leptin replacement 
as a treatment for obesity is currently being explored. 
3.2.2 Overeating 
Overeating leads to weight gain, especially if the diet is high in fat. Foods high in fat or 
sugar (for example, fast food, fried food, and sweets) have high energy density (foods 
that have a lot of calories in a small amount of food). Epidemiologic studies have shown 
that diets high in fat contribute to weight gain. 
A diet high in simple carbohydrates The role of carbohydrates in weight gain is not 
clear. Carbohydrates increase blood glucose levels, which in turn stimulate insulin 
release by the pancreas, and insulin promotes the growth of fat tissue and can cause 
weight gain. Some scientists believe that simple carbohydrates (sugars, fructose, 
desserts, soft drinks, beer, wine, etc.) contribute to weight gain because they are more 
rapidly absorbed into the bloodstream than complex carbohydrates (pasta, brown rice, 
grains, vegetables, raw fruits, etc.) and thus cause a more pronounced insulin release 
after meals than complex carbohydrates. This higher insulin release, some scientists 
believe, contributes to weight gain. 
Frequency of eating The relationship between frequency of eating (how often you eat) 
and weight is somewhat controversial. There are many reports of overweight people 
eating less often than people with normal weight. Scientists have observed that people 
who eat small meals four or five times daily, have lower cholesterol levels and lower 
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and/or more stable blood sugar levels than people who eat less frequently (two or three 
large meals daily). One possible explanation is that small frequent meals produce stable 
insulin levels, whereas large meals cause large spikes of insulin after meals. 
The primary sources of these extra carbohydrates are sweetened beverages, which now 
account for almost 27 percent of daily food energy in young adults in America,28 and 
potato chips.29 Consumption of sweetened drinks such as soft drinks, fruit drinks, iced 
tea, and energy and vitamin water drinks is believed to be contributing to the rising rates 
of obesity30,31 and to an increased risk of metabolic syndrome and type 2 
diabetes.30 Vitamin D deficiency is related to diseases associated with obesity.32 
3.2.3. Physical inactivity 
Sedentary people burn fewer calories than people who are active. The National Health 
and Nutrition Examination Survey (NHANES) showed that physical inactivity was 
strongly correlated with weight gain in both sexes. 
3.2.4 Medications 
Medications associated with weight gain include certain antidepressants(medications 
used in treating depression), anticonvulsants (medications used in 
controlling seizures such as carbamazepine [Tegretol, Tegretol XR, Equetro, Carbatrol] 
and Valproate [Depacon, Depakene]), some diabetes medications (medications used in 
lowering blood sugar such as insulin, sulfonylureas, and thiazolidinediones), certain 
hormones such as oral contraceptives, and most corticosteroids such as prednisone. 
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Weight gain may also be seen with some high blood pressure medications 
and antihistamines. The reason for the weight gain with the medications differs for each 
medication. If this is a concern for you, you should discuss your medications with your 
physician rather than discontinuing the medication, as this could have serious effects. 
3.2.5 Psychological factors 
For some people, emotions influence eating habits. Many people eat excessively in 
response to emotions such as boredom, sadness, stress, or anger. While most overweight 
people have no more psychological disturbances than normal weight people, about 30% 
of the people who seek treatment for serious weight problems have difficulties with 
binge eating. 
Diseases such as hypothyroidism, insulin resistance, polycystic ovary syndrome, and 
Cushing's syndrome are also contributors to obesity. 
3.2.6 Social issues 
A link between social issues and obesity has been established. Lack of money to 
purchase healthy foods or lack of safe places to walk or exercise can increase the risk of 
obesity. 
3.3 Types of Obesity 
Fat is known to have two main purposes, says Susan Fried, Director of Boston Obesity 
and Nutrition research Centre at Boston University.  
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Fat stores excess calories in a safe way to mobile the fat stores and fat releases the 
hormones that control metabolism.  
There are various types of fat as follows Brown, White, Subcutaneous, Visceral and belly 
fat. 
 
Figure 1 Types of fat 
3.3.1 Subcutaneous Fat 
That pinchable fat is soft belly fat, also known as subcutaneous adipose fat located just 
below the skin and intramuscular fat tissue that is deployed within the skeletal muscle, 
acts as insulation and a source of energy for your body. 
In the lower abdominal area, panniculus adiposus is the fatty layer of the subcutaneous 
tissues, superficial to a deeper vestigial layer of muscle, the panniculus carnosus.33 
13 
 
Panniculus, sometimes referred to incorrectly as FUPA (Fat Upper Pelvic Area) or 
pannus, is a medical term describing a dense layer of fatty tissue growth, consisting of 
subcutaneous fat in the lower abdominal area. 
 
Figure 2 Panniculus in standing patient 
Panniculi can form after rapid weight loss, as seen with strict exercise plans - in this case, 
the abdominal fat is successfully reduced, but excess skin is left behind which hangs 
loosely over the area. It can be a result of obesity and can be mistaken for a tumor or 
hernia. Abdominal panniculus can be removed during abdominal panniculectomy, a type 
of abdominoplasty. A panniculus can also be the result of loose tissues after pregnancy 
or massive weight loss.34 
3.3.2 Visceral Fat 
Visceral fat is also called hard belly fat or central obesity, is located deep in your 
abdominal cavity around the vital organs (liver, heart, kidneys). Intra-abdominal or 
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visceral fat has been associated with the deleterious effects on human health. Visceral 
obesity is the most dangerous fat than subcutaneous fat. The main negative effect of the 
lower sensitivity to insulin, a hormone that helps glucose to enter the body’s cells i.e 
diabetes type 2 diabetes35,36,  inflammatory diseases37.  More obvious physiological 
abnormalities of visceral obesity which include – high triglycerides, high blood pressure, 
high blood sugar and low HDL (good cholesterol) under a single term – metabolic 
syndrome. Visceral obesity increases risk for cardiovascular disease. Among the 
deposits of fat, visceral fat is the most active, and mobilize substances secreted in the 
greatest quantities, releases a lot of fatty acids (products of degradation of fats) in the 
bloodstream. 
3.3.3 Inactivity Obesity 
Lack of physical activity can cause overweight in this type of obesity, trunk parts of the 
body quickly gain fat and become unhealthy. 
3.3.4 Android Obesity or Food Obesity 
In this type of obesity the body's extra fat gets distributed over the abdominal region of 
the body of the obese individual and the person's body's shape seems to be apple shaped. 
If the body mass index for any person is 30 or more, then he or she has android 
obesity disease. If you overindulge in unhealthy foods you suffer from food obesity, 
excessive sugar intake can also cause food obesity, which lead to accumulation of fat 
around the middle part of the body. 
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Figure 3 Types of obesity 
3.3.5 A Gynoid (or Pear Shaped) 
This body type is typically defined as a rounder lower half of the body, with 
more fat deposited in the hips, buttocks and thighs. Anxiety or depression can often lead 
to overeating and accumulation of fat in the body, since the body must constantly survive 
in fight or flight mode. To treat this type of obesity, you must control your anxiety.  
3.3.6. Venous Obesity 
Its cause is genetic in nature, rather than habitual in nature. If anyone in your family 
suffers from venous circulation, you run the risk of the same condition. This type of 
obesity is particularly common in pregnancy. Exercise is the best solution for this 
problem. 
3.3.7 Atherogenic obesity 
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People whose fat tends to accumulate in the stomach area often suffer from atherogenic 
obesity. This is a particularly dangerous condition since it can affect your other organs 
and lead to breathing problems. It is extremely important to avoid drinking alcohol if 
you have atherogenic obesity. 
3.3.8 Gluten Obesity 
No stranger to many health problems that gluten can actually cause obesity. This type of 
weight gain is most common in women. It is often spotted during the periods of hormonal 
change like puberty, pregnancy and menopause. The accumulation of muscle mass 
through activities like lifting weights is the most effective treatment for this condition to 
combat gluten obesity. In all cases it comes down to the same basic concepts: decreasing 
your calorie-intake, increasing your physical activity, avoiding alcohol and smoking. 
3.4 Obesity Prevalence 
Globally, there are 1.5 billion adults who are either overweight or obese, a number 
expected to increase to 3 billion by 2030. Obesity in India has reached epidemic 
proportions in the 21st century, with morbid obesity affecting 5% of the country's 
population. India is following a trend of other developing countries that are steadily 
becoming more obese. Obesity is a major risk factor for cardiovascular disease and 
metabolic disorders. In addition to inadequate eating habits, a sedentary lifestyle is the 
main cause of obesity. The point prevalence is higher in women (15%) than in men 
(11%).38 
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3.5 Obesity Pathophysiology 
3.5.1 Role of Lipotoxicity and Inflammation on Obesity 
White adipose tissue (WAT) releases pre–fatty acids and adipokines, which are lipotoxic 
and inflammatory and result in diverse effects, outlined in the left-hand columns. Their 
correlation to the metabolic syndrome is shown on the right-hand column, whereas all 
the effects culminate in atherosclerosis are in the bottom of the figure. 
The excessive fatty acids from lipolysis, which is stimulated by the enhanced 
sympathetic state existing in obesity. The release of these excessive free fatty acids then 
incites lipotoxicity, as lipids and their metabolites create oxidant stress to the 
endoplasmic reticulum and mitochondria. This affects adipose as well as non-adipose 
tissue, accounting for its patho-physiology in many organs, such as liver and pancreas, 
and in the metabolic syndrome.39,40 The free fatty acids released from excessively stored 
triacylglycerol deposits also inhibit lipogenesis, preventing adequate clearance of serum 
triacylglycerol levels that contribute to hypertriglyceridemia.  
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Figure 4 Pathophysiology of Obesity 
Release of free fatty acids by endothelial lipoprotein lipase from increased serum 
triglycerides within elevated β lipoproteins causes lipotoxicity that results in insulin-
receptor dysfunction. The consequent insulin-resistant state creates hyperglycemia with 
compensated hepatic gluconeogenesis. The latter increases hepatic glucose production, 
further accentuating the hyperglycemia caused by insulin resistance. Free fatty acids also 
decrease utilization of insulin-stimulated muscle glucose, contributing, further to 
hyperglycemia.41,42 Lipotoxicity from excessive free fatty acids also decreases secretion 
of pancreatic β-cell insulin, which eventually results in β-cell exhaustion.43 
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3.5.2 Role of inflammation and immune dysfunction in obesity 
The immune dysfunction (left column) and inflammation (center column with arrows) 
are correlated with atherosclerotic lesions (right column). 
 
Figure 5: Formation of atherosclerotic lesions 
Abdominal obesity, due to intra-abdominal adiposity, changes the secretion of 
adipokines. This occurs both through altered secretion of adipocyte-derived biologically 
active substances (adipokines), including free fatty acids, adiponectin, interleukin-6, 
tumour necrosis factor alpha, and plasminogen activator inhibitor-1. 
3.5.2.1 Adiponectin 
Key properties of adiponectin is to promote anti-atherogenic effect, reduce risk of 
developing diabetes, reduce differentiation of macrophages into foam cells, reduce 
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atherogenic vascular remodelling, reduce hepatic glucose output, increase  insulin 
sensitivity. In abdominal obesity secretion of adiponectin reduces and due to it insulin 
sensitivity  decreases i.e. risk of diabetes increases, differentiation of macrophages into 
foam cells getting  increases, atherogenic vascular remodelling increases hepatic glucose 
output increases.44,45 
3.5.2.2 IL-6: Interleukin-6 
Key properties of  IL-6 is to promote inflammation, promote pro-atherogenic effect, 
promote diabetes, increase Vascular inflammation, increase  Hepatic C-reactive protein 
production, reduce Insulin signaling. In abdominal obesity secretion of IL-6 increases 
and due to it Insulin signalling reduces i.e., risk of diabetes increases, risk of 
inflammation increases.46-48 
3.5.2.3 TNFa: tumour necrosis factor alpha 
Properties of TNFa are Pro-atherogenic/pro-diabetic effect ie. decrease in Insulin 
signaling, increase in secretion of other pro-inflammatory mediators. In abdominal 
obesity secretion of TNFa increases and due to that Insulin signaling reduces ie. risk of 
diabetes increases and risk of inflammation increases.46,47,48 
3.5.2.4 C-reactive protein 
Properties of C-reactive protein is to promote inflammation, promote pro-atherogenic 
effect, promote chronic low-grade inflammation predict adverse cardiovascular 
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outcomes. In abdominal obesity secretion of C-reactive protein increases and due to that 
risk of inflammation increases.46,47,49 
3.5.2.5 PAI-1 (plasminogenactivator inhibitor-1) 
 Its Properties are to promote Pro-atherogenic effect and pro-coagulant effect, increase 
Atherothrombotic risk. In abdominal obesity secretion of PAI-1 increases the risk of  
Atherosclerosis.46,47 
3.6 Physiology of Fat Metabolism: Overview and Synthesis 
3.6.1 Pathways of the Fat System 
Lipolysis: hydrolysis of triacylglycerol to glycerol and free fatty acids 
β-Oxidation: mitochondrial oxidation of fatty acids -----ENERGY! 
Ketogenesis: synthesis of ketone bodies 
Lipogenesis: fatty acid synthesis 
Esterification: attachment of fatty acids to glycerol to form triglycerides 
Cholesterolgenesis: synthesis of cholesterol 
Steroidogenesis: synthesis of steroid hormones from cholesterol 
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3.6.2 Interactions of Fat Metabolism Pathways 
 
Figure 6: Fat metabolism pathway 
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3.6.3 Fat Metabolism in Specific Tissues 
 
Liver: oxidizes fats, produces ketones, exports triglycerides 
Muscle: uses fats and ketones as an energy source 
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Adipose Tissue: stores fats as triacylglycerol and releases fatty acids as needed 
for energy 
Mature RBC's (no mitochondria) / Brain (lack of enzymes): do not use fats for 
energy 
3.6.4 Fatty Acid Synthesis (Lipogenesis) 
Export of Acetyl CoA for Fatty Acid Biosynthesis 
AcetylCoA mit + 2ATP + NADH + NADP+ ---> AcetylCoA cyt + 2ADP + 2Pi + NAD+ + 
NADPH 
 
AcetylCoA Carboxylase: Acetyl CoA + HCO3- + ATP ----> Malonyl CoA 
Committed Step, Highly Regulated 
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Fatty Acid Synthase: 
AcetylCoA + 7MalonylCoA + 14NADPH + 14H+ ---> Palmitate + 7CO2 + 8CoA + 
14NADP+ 
Dimeric Enzyme: each monomer has 7 enzyme activities 
Primary Product: palmitic acid 
Purpose: process the fatty acid chain through 7 cycles to produce the 16-C product; 4 
C's are introduced in the first cycle from Acetyl CoA and Malonyl CoA; subsequent 
cycles 2 C units are derived from Malonyl CoA following the release of CO2 
ACP = Acyl Carrier Protein 
CE = Condensing Enzyme 
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 ACP on one monomer is in close proximity to CE on the other monomer. The 
initial steps result in attachment of an acetyl group from acetyl CoA on CE and 
the malonyl group from malonyl CoA on ACP. 
 The acetyl group on CE condenses with the malonyl residue on ACP with the 
release of CO2. 
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 The ACP bound intermediate undergoes reduction by NADPH, dehydration, 
second reduction (NADPH). 
 The 4 C fatty acid is transferred to the CE preparing the ACP for attachment of a 
second malonyl CoA. 
 Malonyl CoA donates a malonyl group to ACP (as previously described). 
 The 4 C group from CE condenses with the second malonyl residue with release 
of CO2. 
 Reduction (NADPH), dehydration, second reduction (NADPH). 
 The cycle is completed with the transfer of the growing hydrocarbon chain to CE. 
 The process continues for 5 more cycles ([4] through [7]) with successive two C 
additions. Once a palmitoyl group is formed on ACP it is cleaved 
by thioesterase releasing palmitic acid (palmitate). 
3.6.5 Acyl-CoA Synthetase 
 
Elongation: microsomal process (ER), requires malonylCoA and two NADPH, process 
is similar to that occurring with fatty acid synthase. 
28 
 
Unsaturation: microsomal process, reduction with NADPH or NADH, molecular 
oxygen is required. 
3.6.6 Regulation of Lipogenesis 
 
3.6.6.1 Conditions Favoring Lipogenesis 
 
3.6.7 Esterification 
Formation of Phosphatidic Acid from Glycerol or Dihydroxyacetone Phosphate and 
its Conversion to Triacylglycerol or Phospholipids. 
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3.7 Pathogenesis of Obesity 
Obesity has been implicated as one of the major risk factors for hypertension (HTN), 
heart failure (HF), and coronary heart disease (CHD).The adipocyte acts as an endocrine 
organ, and plays a substantial role in the pathogenesis and complications of obesity.52-54 
Increased levels of leptin (an adipocyte-derived hormone) which reduces food intake and 
reduces energy metabolism by increasing insulin resistance, increases CV disease by 
increasing vascular injury. C-reactive protein (CRP) may play a vital role in the 
development of leptin resistance, which is important because endogenous 
hyperleptinemia does not reduce appetite or increase energy expenditure.50.51 
3.7.1 Body Mass Index (BMI) 
3.7.1.1 Height 
Using standard measuring tape, height in meters or centimetres or inches of each patient 
would be measured. 
3.7.1.2 Weight 
Using standard measuring weighing machine KRUPS, ESSAE, EEROKA LTD to 
measure the weight in kilogram or pounds of each patient. 
The body mass index (BMI) is a value derived from the mass (weight) and height of an 
individual. The BMI is defined as the body mass divided by the square of the body 
height, and is universally expressed in units of kg/m2, resulting from mass 
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in kilograms and height in metres. The most commonly used definitions, established by 
the World Health Organization(WHO) in 1997 and published in 2000, provide the values 
listed in the below Table 155-57. 
Table 1 WHO Classification of BMI 
BMI Classification 
< 18.5 Underweight 
18.5–24.9 normal weight 
25.0–29.9 Overweight 
r30.0–34.9 class I obesity 
35.0–39.9 class II obesity 
≥ 40.0 class III obesity 
 
3.8. Clinical Features 
3.8.1 Obesity Sign 
Signs of overweight and obesity include a high body mass index (BMI) and an unhealthy 
body fat distribution that can be estimated by measuring your waist circumference. 
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3.8.2 Obesity Symptoms 
1. Gastroesophageal reflux disease (GERD) 
2. High blood pressure 
3. High cholesterol 
4. Heart disease and blood lipid abnormalities. 
5. Joint disease (e.g., osteoarthritis) type 2 diabetes. 
6. Snoring 
7. Breathing disorders (e.g., sleep apnea, chronic obstructive pulmonary disease) 
8. Increased sweating 
9. Inability to cope with sudden physical activity 
10. Feeling very tired every day 
11. Low confidence and self-esteem 
12. Feeling isolated 
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3.8.3 Obesity Complication 
 
Figure 7: Complication of obesity 
Obesity increases total blood volume and cardiac output, and cardiac workload is greater 
in obesity. Typically, obese patients have a higher cardiac output but a lower level of 
total peripheral resistance at any given level of arterial pressure58,59. Most of the increase 
in cardiac output with obesity is caused by stroke volume, although because of increased 
sympathetic activation, heart rate is typically mildly increased as well.60 Obese patients 
are more likely to be hypertensive than lean patients, and weight gain is typically 
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associated with increases in arterial pressure59,60 due to increased filling pressure and 
volume, overweight and obese individuals often develop left ventricular (LV) chamber 
dilation.58,60,61 Independent of arterial pressure and age, obesity increases the risk of left 
ventricular hypertrophy (LVH), as well as other structural abnormalities, obesity also 
leads to left atrial (LA) enlargement, both from increased circulating blood volume as 
well as abnormal LV diastolic filling.58,62 These abnormalities not only increase the risk 
of HF, but LA enlargement may increase the risk of atrial fibrillation (AF).In addition to 
increasing LV structural abnormalities and the propensity for more frequent and complex 
ventricular arrhythmias60, obesity also has adverse effects on diastolic and systolic 
function58,62. 
3.9 Stress and Obesity 
3.9.1 Research Study: Stress Cause Excess Abdominal Fat in Lean Woman 
Women who are vulnerable to the effects of stress are more likely to have excess 
abdominal fat, and have higher levels of the stress hormone cortisol, a study conducted 
at Yale suggests. 
While past studies have examined cortisol response in overweight women, this is the 
first study to show that lean women with abdominal fat have exaggerated responses to 
cortisol. Abdominal fat is related to worse health, including greater risk of heart disease 
and diabetes. 
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“We also found that women with greater abdominal fat had more negative moods and 
higher levels of life stress,” said Elissa S. Epel, Ph.D., lead investigator on the study she 
conducted while at Yale's psychology department. “Greater exposure to life stress or 
psychological vulnerability to stress may explain their enhanced cortisol reactivity. In 
turn, their cortisol exposure may have led them to accumulate greater abdominal fat.” 
Published in the September/October issue of Psychosomatic Medicine, the study looked 
at pre-menopausal, non-overweight women, and overweight women who stored fat 
either centrally-at the waist vs. peripherally-at the hips, and examined their stress 
responses over three consecutive days.63 
Cortisol affects fat distribution by causing fat to be stored centrally-around the organs. 
Cortisol exposure can increase visceral fat-the fat surrounding the organs-in animals. 
People with diseases associated with extreme exposure to cortisol, such as severe 
recurrent depression and Cushing's disease also have excessive amounts of visceral fat. 
“Everyone is exposed to stress, but some people may secrete more cortisol than others, 
and may secrete cortisol each time they face the same stressor,” Epel adds. “We predicted 
that reacting to the same stressors consistently by secreting cortisol would be related to 
greater visceral fat.”64 
After the first exposure to stress, women with greater abdominal fat felt more threatened 
by the study's stressful tasks, performed more poorly on them, and secreted more 
cortisol. They also reported more life stress. By the third exposure to stress, the lean 
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women with abdominal fat still consistently secreted more cortisol in response to 
stressful lab tasks, compared to women with peripheral fat.63,65 
“It is possible that greater exposure to stressful conditions or psychological vulnerability 
to stress has led them to overreact to stressors in their daily lives, so they have had greater 
lifetime exposure to cortisol,” Epel said. “Cortisol, in turn may have caused them to 
accumulate abdominal fat. Genetics, however, also play a role in shaping reactivity to 
stress, as well as body shape.”63 
Lifestyle and age may also influence levels of abdominal fat. Smoking, alcohol and lack 
of exercise all contribute to greater abdominal fat. Postmenopausal women tend to carry 
fat at their abdomen, due to changes in sex hormones. Epel said a healthy lifestyle, 
including getting enough sleep, exercise and relaxation, may reduce cortisol levels. 
“These relationships likely apply to men as well,” Epel said. “However, excess weight 
on men is almost always stored at the abdomen. On the contrary, in pre-menopausal 
women, excess weight is more often stored at the hips. Therefore, for women, it is 
possible that stress may influence body shape more than for men, leading to abdominal 
fat instead of lower body fat accumulation.”64 
3.10 Conventional Management  
3.10.1 Dieting 
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Diets to promote weight loss are generally divided into four categories: low-fat, low-
carbohydrate, low-calorie, and very low calorie.66 A meta-analysis of six randomized 
controlled trials found no difference between three of the main diet types (low calorie, 
low carbohydrate, and low fat), with a 2–4 kilograms (4.4–8.8 lb) weight loss in all 
studies.66.At two years these three methods resulted in similar weight loss irrespective of 
the macronutrients emphasized.67 High protein diets do not appear to make any 
difference.68 A diet high in simple sugars such as those in soft drinks increases weight.69 
Very low calorie diets provide 200–800 kcal/day, maintaining protein intake but limiting 
calories from both fat and carbohydrates. They subject the body to starvation and 
produce an average weekly weight loss of 1.5–2.5 kilograms (3.3–5.5 lb). These diets 
are not recommended for general use as they are associated with adverse side effects 
such as loss of lean muscle mass, increased risks of gout, and electrolyte imbalances. 
People attempting these diets must be monitored closely by a physician to prevent 
complications.66 
3.10.2 Physical Exercise 
 Muscles consume energy derived from both fat and glycogen. Due to the large size of 
leg muscles, walking, running, and cycling are the most effective means of exercise to 
reduce body fat.70 Exercise affects macronutrient balance. During moderate exercise, 
equivalent to a brisk walk, there is a shift to greater use of fat as a fuel.71,72 To maintain 
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health, the American Heart Association recommends a minimum of 30 minutes of 
moderate exercise at least 5 days a week. 
Perform 20-30 minutes of moderate exercise five to seven days a week, preferably daily. 
Types of exercise include stationary bicycling, walking or jogging on a treadmill, stair 
climbing machines, jogging, and swimming.71 Exercise can be broken up into smaller 
10-minute sessions. 
Start slowly and progress gradually to avoid injury, excessive soreness, or fatigue. Over 
time, build up to 30-60 minutes of moderate to vigorous exercise every day. 
People are never too old to start exercising. Even frail, elderly individuals (70-90 years 
of age) can improve their strength and balance.70 
High fat diet leads to obesity, which enhances the systemic inflammation (TNF- 
α) and causes fibrosis leading to cardiac dysfunction. Exercise decreases high fat diet 
induced obesity, upregulates anti-inflammatory IL-10, which reduces inflammation, 
mitigates fibrosis, and ameliorates cardiac dysfunction.71 
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Figure 8 Benefits of exercise 
3.11Pharmacotherapy 
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The above Drug for obesity were approved by the U.S. Food and Drug 
Administration (FDA) that produce weight loss. [Reprinted from "Update on obesity 
pharmacotherapy", by Bray GA, Ryan DH, 2014, Ann N Y Acad Sci, 1311, pp.1-13. 
Copyright 2014 by by John Wiley & Sons, Inc. Reprinted with permission].73,74 
3.11.1 Non-surgical liposuction  
In this  techniques using laser energy, radiofrequency, ultrasound or cold (cryolipolysis) 
to reduce fat.75 Devices are applied directly to the skin of the treatment area and do not 
employ injections (as in injection lipolysis) or incisions (as in laser assisted liposuction). 
Although fat loss is more subtle with non-surgical lipolysis techniques compared to 
surgical liposuction, non-surgical lipolysis techniques have several advantages including 
reduced risk, reduced cost, and reduced healing time.76 Laser,77 radiofrequency,78 and 
ultrasound79 techniques provide additional advantages of tissue tightening.80 
3.11.2 Surgical Approach 
3.11.2.1 Bariatric surgery 
It is the weight loss surgery includes a variety of procedures performed on people who 
have obesity. Weight loss is achieved by reducing the size of the stomach with a gastric 
band or through removal of a portion of the stomach  or by resecting and re-routing 
the small intestine to a small stomach pouch (gastric bypass surgery).Long-term studies 
show the procedures cause significant long-term loss of weight, recovery from diabetes, 
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improvement in cardiovascular risk factors, and a mortality reduction from 40% to 
23%.1 The U.S. National Institutes of Health recommends bariatric surgery for obese 
people with a body mass index (BMI) of at least 40, and for people with BMI of at least 
35 and serious coexisting medical conditions such as diabetes.81  
3.11.2.2 Liposuction 
Liposuction, or simply lipo, is a type of cosmetic surgery that removes fat from the 
human body in an attempt to change its shape.82.The procedure may be performed under 
general, regional, or local anesthesia. It then involves using a cannula and negative 
pressure to suck out fat.84.Weight loss from liposuction appears to be of a short term 
nature with little long term effect.83 After a few months fat typically returns and 
redistributes.83 Liposuction does not help obesity related metabolic disorders like insulin 
resistance.84 
 It is believed to work best on people with a normal weight and good skin elasticity85. In 
the United States it is the most commonly done cosmetic surgery.85,86 Serious 
complications include deep vein thrombosis, organ perforation, bleeding, 
and infection.87 Death occurs in about one per ten thousand cases. 
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3.12 Obesity and Bastrika Pranayama 
3.12.1 Yoga and Health 
Yoga is one of the six systems of Indian Vedic philosophy (Darshan). Maharishi 
Patanjali, rightly known as the “Father of Yoga”, compiled and refined various aspects 
of yoga systematically in his “Yoga Sutras” (aphorisms), wherein he advocated the eight-
fold path known as “Ashtanga Yoga” for an all-around development of human 
personality. These include Yama [moral odes], Niyama [self-purification and 
study], Asana [posture], Pranayama [breathcontrol], Pratyahara [sense 
control], Dharana [concentration], Dhyana [meditation],and Samadhi [super 
contemplation]. These are formulated on the basis of multifarious psychological 
understanding of human personality. 
Other aspects of yoga philosophies are broadly classified into four streams namely Work, 
Worship, Philosophy, and Psychic control. “Karma Yoga,” the path of work, promotes 
pleasure in labor without indulging in thoughts of success or failure. A free mind allows 
the task to be done in a skillful manner. “Bhakti Yoga,” the path of worship, is a 
systematic method of engaging the mind in the practice of divine love. This attitude of 
love softens our emotions and tranquilizes our mind. “Gyana Yoga,” the path of 
philosophy, is a systematic way of enlightening the mind about the realities of life by 
contemplation. This will strip off the garb of Avidya (ignorance) from our mind as it 
goes to its natural state of rest.  
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“Raja Yoga,” the path of psychic control, is a systematic process of culturing the mind. 
It is based on the eight-fold path set by Patanjali. 
La forge (1997) revealed that Mind-body practice with existing health promotion and 
cardiac rehabilitation services can improve the self-efficacy and long-term adherence to 
healthy behaviors. It can as well improve the personal stress management skills. There 
are also numerous primary and secondary preventive indications for cardiovascular 
disease (CVD) where the mind-body exercise plays a primary or complementary role.88 
Ives JC et.al. (2000)suggested that mind-body exercise methods are now used widely in 
the health, fitness, and rehabilitation fields. Yoga helps to reduce stress, decrease 
hypertension, and also exerts cardiorespiratory benefits.89 
Yank et.al. (2007) reviewed papers to find out the effects of yoga intervention especially 
on the common risk factors of chronic diseases like overweight, hypertension, high 
glucose level and high cholesterol. A systematic search yielded 32 articles published 
between 1980 and april 2007 which revealed that the yoga interventions are generally 
effective in reducing body weight, blood pressure, glucose level and high cholesterol. 90 
Kiecolt G et.al. (2010) observed that the stress factors like serum interleukin (IL)-6 levels 
and C-reactive protein (CRP) are higher in the novices than the yoga experts. It is found 
that IL-6 promotes CRP Production. The yoga experts produced less lipopolysaccharide-
stimulated IL-6 in response to the stressor than novices.91 
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Smith et.al. (2011) concluded that yoga when practiced in a more integrated form, i.e., 
with an ethical and spiritual component provides additional benefits over yoga than when 
practiced as an exercise regimen.92 
Innes KE et.al. (2007) study suggests that chronic stress and related psychosocial factors 
also play an important role in the development and progression in the pathogenesis of 
cardio vascular diseases. Integrated psychological and physiological components of 
health, yoga and other traditional mind-body therapies may offer particular promise in 
both the primary and secondary prevention of CVD.93. 
Yoga and meditation has also been commonly used for muscle relaxation. (Ghoncheh,  
S, & Smith, J C, 2004).Yoga can be performed by most people, including young people 
and cardiac patients (Ades, P A. et.al., 2003),( Tran, M. et.al., 2001), (Raub, J, 2002) 
(Dash, M, & Telles, S, 2001).Yoga builds up a core stability during and after pregnancy 
(Berk, B, 2001) and it increases the creativity and reduces stress, (Khasky, A D, Smith, 
J C, 1999)as well as to improve muscle power, dexterity, visual perception, (Raghuraj, 
P, & Telles, S, 1997)and reaction time (Madanmohan et.al.,1993) while strength, 
endurance, and muscle reaction times which have been quantified previously, but little 
has been done to quantify the muscle use during yoga practice (Narayan, R. et.al., 1990), 
(Dostalek, C. et.al., 1979) 
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3.12.2 Yoga and Obesity 
Seo et al. 2012 show that an 8-week of yoga training improves body composition and 
total cholesterol levels in obese adolescent boys, suggesting that yoga training may be 
effective in controlling some metabolic syndrome factors in obese adolescent boys.94 
 
Telles S et al. 2010 found that short term intensive yogic practice with modified diet 
pattern for 6-days can decrease the BMI, free fat mass, waist: hip ratio, serum leptin and 
also promote better postural stability and hand grip strength.95 
 
Collins C et al. 1988 Yoga training may help obese adolescents to achieve the 
recommended levels of physical activity, and it may be an alternative exercise training 
programs because it has limited harmfulness, and requires virtually no equipment.96 
 
Lee JA et al. 2012 a study showed that yoga can improves adiponectin level, serum 
lipids, and metabolic syndrome risk factors in obese postmenopausal women and 
effective in preventing cardiovascular disease caused by obesity in obese 
postmenopausal Korean women.97 
 
Vijay T et al. 2012 conducted study on effect of certain yogic postures and breathing 
techniques suggested that there is significant decrease in the parameters of obesity 
mainly the Body Mass Index and Waist Hip Ratio.98 
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Dhananjai S et al. 2011 a study indicates usefulness of yoga practices in reducing obesity 
and reduces risk factors associated with obesity and suggested the useful in management 
of obesity without any side effects.99 
 
Braun et al. 2012 suggested that Kripalu yoga-based, residential weight loss program 
suggests the psychological well-being, improved nutrition behaviors, and weight loss in 
obese individuals.100 
 
Okonta NR, 2012 study suggested that yoga not only reduce high BP, but it has also been 
very effective in reduction of blood glucose level, cholesterol level, and body weight, 
major problems affecting the American society.101  
 
Littman et al. 2012 showed that six month intensive yoga program on overweight and 
obesity breast cancer survivors can decrease waist circumference and improve quality of 
life.102 
Pranayam (yoga breathing) involves controlling the respiratory functions of the body 
which is generally involuntary under the human control. We live because we breathe. 
But there are certain breathing techniques which if properly done can bring about energy, 
cheerfulness and improve the health of the individual. We breathe in through the nose 
and the lungs function in retaining the breath and it is later exhaled.  
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The breathing process depends on the health of the heart and lungs. If these are organs 
are healthy then breathing can occur normally. Thus in normal breathing inhalation and 
exhalation is not connected with the mind and hence it is not controlled. Moreover 
inhalation and exhalation does not occur in correct duration of time. Sometimes 
inhalation occurs for more period of time than the exhalation. In pranayam, the breathing 
procedure is connected with the mind and hence there is specific duration of breathing. 
This helps in making a healthy body. The person becomes cheerful and can help in 
managing various disorders. Pranayam helps in improving the supply of the oxygen. It 
can immensely improve the functioning of the lungs and initiate the proper way of 
breathing. It can thus provide a sense of well being and help to maintain a healthy heart. 
It prevents the development of various respiratory disorders. It helps in the management 
of respiratory disorders if an individual is already suffering from it. 
It keeps the body young and assists in weight loss. It improves the quality of blood and 
can enhance the mental health. 
3.13 Bastrika Pranayama (Bellows Breathing) 
3.13.1 Procedure for Pranayama Getting ready for Pranayama 
 Participants were instructed to sit in padmasana position (cross-legged on the floor with 
the feet on the thighs and the soles facing upwards) with relaxed body and erect spine. 
The hands were to be kept on the knees in Gyan Mudra Posture (the tips of the index 
fingers to be joined to the tips of the thumbs while keeping the other fingers extended 
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and loose). Eyes were to be closed gently. Body and the mind were to be relaxed for 2 
minutes (min) followed by 3 min of normal breathing before starting the procedure.  
 The participants were asked to take a deep breath in and breathe out forcefully through 
the nose.  Immediately afterwards breathe in with the same force. During inhalation the 
diaphragm descends and the abdomen moves outward. During exhalation the diaphragm 
moves upward and the abdomen moves inward. The above movements should be slightly 
exaggerated. Continue in this manner, counting 10 breaths. At the end of 10 breaths, take 
a deep breath in and breathe out slowly. This was continued for 4 minutes (min) which 
was considered as one round of bhastrika pranayama. This was followed by 1min 
rest.This 4 min bastrika pranayama with one min gap was repeated two times and at the 
end of this, 3 min rest was followed. Altogether this one round was spanned for 10 min 
twice a day for morning and evening for 8 weeks. 
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Figure 9: Participant practicing Bhastrika Pranayama (individual practice) 
 
Figure 10: Participant practicing Bhastrika Pranayama (Group Practice) 
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Figure 11: Group practice of Bhastrika Pranayama with the principal investigator 
 
Placing both soles of the feet on top of the thighs is padmasana which destroys all sins 
(bad karma).  
 
Sitting properly in padmasana, keeping neck and abdomen in alignment,exhale prana 
through the nose.  
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And again the air should be quickly inhaled up to the heart lotus. Accordingly, the 
resounding is felt from the heart and throat up to the cranium. 
 
In that way it (the breath) is inhaled and exhaled repeatedly, with the same motion as a 
pair of bellows being pumped 
.  
Thus, in this way, one keeps the breath moving with mindfulness (awareness) and body 
steadiness. When the body is tired then inhale through the right nostril.  
 
Accordingly, when the abdomen becomes full of air, then quickly hold the nostrils (and 
breath) firmly, without using the index and middle fingers (i.e. using the thumb and ring 
finger as in nasikagra mudra).103 
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Having performed (pranayama and) retention systematically, exhale through the left 
nostril. Thereby imbalances of wind, bile and mucus are annihilated and the digestive 
fire increased. Bhastrika is the name of the pranayama which imitates the action of the 
bhastra or ‘bellows’ and fans the internal fire, heating the physical and subtle bodies. 
Bhastrika pranayama is similar to vatakrama kapalbhati, but in bhastrika, inhalation and 
exhalation are equal and are the result of systematic and equal lung movements. The 
breath has to be sucked in and pushed out with a little force. In kapalbhati, inhalation is 
the result of forced exhalation. Bhastrika should not be done so forcefully that the nostrils 
are sucked in with inhalation. The air creates a sound as it passes in and out of the nose, 
but it should not be a heavy sound. It should come from the nose and not the throat. 
Throughout the practice the body should remain steady. The shoulders and chest should 
not move at all, only the lungs, diaphragm. The correct sitting position for bhastrika is 
padmasana, but if it cannot be practiced, ardha padmasana or siddhasana/siddha yoni 
asana are good alternatives. In padmasana and siddhasana the body is firmly locked so 
that physical movement is restricted and the spine remains straight. Nervous impulses 
are then able to travel directly up through the central nervous system. Siddhasana also 
maintains the blood pressure.103 
Preparation: 
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Sit comfortably in your meditative posture with the hands on the knees and the eyes 
closed. 
Take a slow deep breath in. Breathe out quickly and forcefully through the nose, but do 
not strain, and immediately afterwards breathe in with the same force. 
When you breathe out the abdomen comes in and the diaphragm contracts. When you 
breathe in the diaphragm relaxes and the abdomen moves out. These movements should 
be slightly exaggerated. 
Continue to breathe in this manner counting ten breaths. At the end of ten breaths, take 
a deep breath in and out slowly. This is one round. Practice three to five rounds. 
As you become accustomed to this style of breathing, gradually increase the speed but 
keep the breath rhythmical. Inhalation and exhalation must be equal.103 
Technique 1 
Stage 1:  
Sit comfortably in your meditative pose, relax and prepare yourself for pranayama. Keep 
the head and spine straight.Place the right hand in nasikagra mudra and close the right 
nostril. Inhale slowly and deeply through the left nostril and then breathe in/out as 
described in the preparation, counting twenty breaths. 
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After completing the last exhalation, breathe in slowly and deeply, close both nostrils 
and bend the head forward into jalandhara bandha, but do not raise the shoulders. Hold 
for as long as comfortable. 
Raise the head and exhale slowly through the right nostril. Take a deep inhalation 
through the right nostril and practice in the same way as you did through the left nostril, 
counting twenty breaths. After the last exhalation, inhale slowly and deeply through the 
right nostril. When inhalation is complete, close both the nostrils and practice jalandhara, 
hold, and release as before. Complete one round by practicing on both sides. Perform 
three rounds.103 
Stage 2:  
Practice as in stage 1, but after practicing through the right nostril, practice through both 
nostrils together counting up to forty breaths. Practice three rounds. 
Stage 3:  
Practice as in stage 2, but during retention add breaths. Practice three rounds. Moola 
bandha after jalandhara. On completion of retention, release moola bandha then 
jalandhara. Practice three to five rounds. 
Stage 4:  
Practice five rounds of stage 3 and increase by ten respirations every week until you are 
breathing in the ratio of 50:50:100 in each round. 
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Technique 2 
Practice Technique 1 stage 4, but omit breathing through alternate nostrils, only breathe 
through both, one hundred times. Instead of performing antar kumbhaka (internal 
retention), practice bahir kumbhaka (external retention). That means, after the last 
exhalation of bhastrika, inhale slowly and deeply, and exhale rapidly through the mouth. 
Perform jalandhara and moola bandha.103 
Release in the same way as described previously. Practice five rounds. After a week or 
so of practice add uddiyana bandha after jalandhara, so that you now perform maha 
bandha with external kumbhaka. 
Release moola bandha, then uddiyana, then jalandhara. Between each round concentrate 
on the natural breath or mid-eyebrow center. Practice five rounds of up to a hundred 
breaths unless your guru asks you to practice more. Bhastrika should be performed after 
asana and nadi shodhana pranayama, but before seetkari, sheetali or ujjayi. During warm 
seasons it should be followed by a few rounds of sheetali/seetkari so that the body does 
not overheat. The number of rounds of bhastrika may also need to be reduced. Those 
people with high blood pressure, heart disease, brain tumor,vertigo, stomach or intestinal 
ulcers, glaucoma, dysentery or diarrhea must not attempt this practice. If dizziness is 
experienced during the practice it means it is being performed incorrectly. Bhastrika 
must always be done in a relaxed manner with full awareness and the mind should not 
be allowed to wander. 
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In Hatharatnavali it is said that after the practice of bhastrika you should listen “with the 
right ear to welcome internally aroused sounds of crickets, flute, thunder cymbals, a 
black bee, bell, gong, trumpet, drum.” 
 
This (bhastrika) quickly arouses kundalini. It is pleasant and beneficial, and removes 
obstruction due to excess mucus accumulated at the entrance to brahma nadi.  
 
This kumbhaka called bhastrika enables the three granthis (psychic/ pranic knots) to be 
broken. Thus it is the duty of the yogi to practice bhastrika.  
                                                   Hatha-Yoga-Pradipika-Muktibodhananda 
Benefits:  
The most important physiological effect of bhastrika is on the brain and heart. Bhastrika 
stimulates the circulation of cerebral fluid and increases the compression and 
decompression upon the brain, creating a rhythmic massage. The rhythmic pumping of 
the diaphragm and lungs stimulates the heart and blood circulation. Accelerated blood 
circulation and rate of gas exchange in each cell produces heat and ‘washes out’ waste 
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gases. Hyperventilation begins to occur and excites the sympathetic nerves in the 
respiratory center, but because there is an increased release of carbon dioxide, the center 
is subsequently relaxed and hyperventilation does not take place. If exhalation were to 
become less than inhalation, then there would be hyperventilation. Therefore, in 
bhastrika inhalation and exhalation must remain equal.103 
The rapid and rhythmic movement of the diaphragm also stimulates the visceral organs 
and this creates a massaging effect throughout the whole system. Bhastrika is the most 
dynamic and vitalizing pranayama techniques. 
Bhastrika heats the nasal passages and sinuses, clearing away excess mucus and building 
up resistance to colds and all respiratory disorders. Therefore, it is useful in the yogic 
management of chronic sinusitis, pleurisy, asthma and bronchitis. Bhastrika improves 
digestion and stimulates a sluggish system. It increases the appetite, accelerates the 
metabolic rate and strengthens the nervous system. Bhastrika also helps in cases of 
tuberculosis, constipation, sciatica, spondylitis, arthritis, rheumatic problems, cancer and 
physical arid mental tension. Pranic movement, particularly in the coccygeal, navel, 
thoracic and brain centers, is accelerated by the practice of bhastrika and this increases 
physical vitality and bestows clarity of mind. The tremendous heat generated by the 
practice clears sushumna nadi and prepares it for the ascent of kundalini. Within 
sushumna there are three granthis or psychic/pranic knots which prevent the passage of 
kundalini shakti. One is found in mooladhara chakra. It is called brahma granthi and it 
ties the awareness to sensual perception and the physical world. Another is in anahata 
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chakra and it causes the desire for emotional security, expression and fulfillment. It is 
called vishnu granthi. The third granthi is located in ajna chakra and is associated with 
attachment to siddhis, psychic phenomena and experiences. It is called rudra granthi. 
The shakti produced by bhastrika is said to break these granthis so that kundalini can 
move on unobstructed. 
Through the practice of bhastrika, the indriya: jnanendriya (sensory organs) and 
karmendriya (motor organs) become less influential in motivating one’s behavior, and 
the need for sensual enjoyment decreases. The nervous system becomes stronger, the 
emotions are harmonized and deeper inner satisfaction results. This occurs when brahma 
and vishnugranthis begin to unknot. When psychic experiences begin, bhastrika helps 
one to remain as a silent uninvolved witness who is not attached to any of these 
experiences. As rudra granthi starts to unfold, this attitude of sakshi (the witness) 
develops. 
It is not easy to loosen the granthis because there are many physical, emotional and 
mental barriers. For the average person it is almost impossible to control sensual desires 
and to live without emotional security and fulfillment. As for psychic experiences, those 
who have them often end up in a mental hospital because they have no guru to guide 
them through their spiritual awakening.103 
So, although bhastrika helps loosen the granthis which obstruct kundalini’s ascent, it is 
not enough just to practice bhastrika for hours together; a guru’s guidance is necessary.103 
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Benefits of Bhastrika Yoga Pranayama (Bellows Breath) 
Primary 
Boosts your metabolic rate so your body burns fat faster promoting natural weight loss. 
Purifies your gross and subtle body by eliminating toxins and waste. 
Generates heat in your body and opens up your energy pathways. 
Builds lung capacity and helps clear and strengthen the respiratory system.104-106 
Secondary 
Expands and fortifies your nervous system. When done forcefully, the pulsating of the 
diaphragm massages the internal organs, thus improving your digestive system.104-106 
Physiology of Bhastrika (Understanding the Bellows) 
Effect of Bhastrika Pranayama on weight loss 
Bhastrika pranayama helps clear your mind and body as part of a purification process,  
bhastrika pranayama helps improves your digestive system function and boosts your 
metabolism, thereby resulting in weight loss. bhastrika pranayama helps break down fats 
in the body,. However, scientific research does not yet validate these claims. 
Additionally, rapid, forceful breathing can make you feel lightheaded.107 
The bhastrika pranayama, or breathing exercise, simultaneously calm and energize the 
practitioner. The process works by increasing the cellular metabolic rate, opening 
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energetic pathways in the body and increasing internal heat, according to Anmol Mehta. 
Bhastrika is also recommended for ridding the body of toxins, strengthening the lungs 
and nervous system and improving digestion. All of these functions work together to 
contribute to weight loss.108 
 
Figure 12: Bhastrika pranayama 
 
Figure 13: Physiology of Bhastrika Pranayama 
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As your lungs become full of oxygen after performing Bharstika, the metabolic and other 
functions of the body are improved. The process of energy production in the cells is 
taken to the next level, as the excess of oxygen in your body accelerates cellular 
metabolism. Enhanced metabolism helps to remove unwanted fats and toxins.109 
Effect of Bhastrika Pranayama on respiration and cardiovascular function: 
University of São Paulo Medical School Sleep Laboratory research involving 76 elderly 
people revealed that those who practiced yoga breathing for four months showed 
improvements compared to a control group that did not practice yoga breathing. 
Individuals who engaged in yogic breathing showed improved respiration patterns and 
more balanced heart rhythms. This study was published in BMJ Open in 2011.107 
 
Figure 14: Bhastrika pranayama and lung function 
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Effect of slow pace bhastrika pranayama on blood pressure and heart rate. 
Slow pace bhastrika pranayama (respiratory rate 6/min) exercise thus shows a strong 
tendency to improving the autonomic nervous system through enhanced activation of the 
parasympathetic system. Vagal cardiac and pulmonary mechanisms are linked, and 
improvement in one vagal limb might spill over into the other baroreceptor sensitivity 
can be enhanced significantly by slow breathing (supported by a small reduction in the 
heart rate observed during slow breathing and by reduction in both systolic and diastolic 
pressure).110 
Bhastrika Pranayama (respiratory rate 6/min) for 5 minutes increases frequency and 
duration of inhibitory neural impulses by activating pulmonary stretch receptors during 
above tidal volume inhalation as in Hering Bruer reflex, which bring about withdrawal 
of sympathetic tone in the skeletal muscle blood vessels, leading to widespread 
vasodilatation, thus causing decrease in peripheral resistance and thus decreasing the 
diastolic blood pressure.110 
Effect of  bhastrika pranayama on cardiovascular autonomic reactivity 
Bhastrika pranayama increase the cardiac autonomic activity - increase in 
parasympathetic activity i.e. reduces basal heart rate, increase in valsalva ratio (ie.forced 
expiration against a closed glottis reduces heart rate) and reduction in sympathetic 
activity i.e., reduction in fall of systolic blood pressure on posture variation.111 
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Effect of bhastrika pranayama on EEG waves 
The effect of bhastrika pranayama on the autonomic nervous system noted that 
increases paroxysmal EEG waves immediately after practice in the healthy 
volunteers.27 During the bhastrika pranayama practice all the subjects exhibited high 
frequency hyprerphasic patterns, biphasic waves. They have found strong 
amplitude gamma waves after 30 days of bhastrika pranayama practice (two sessions per 
day). It was further concluded that continuous practice would causethe waves to remain 
for several minutes even after the practice is finished.112 
Effect of bhastrika (a bellows type pranayama) on reaction time in mentally 
challenged adolescents. 
Bhastrika pranayama decrease the Reaction time by improving the central neuronal 
processing ability and helps for greater arousal and faster rate of response to information 
processing, improve concentration, increases ability to ignore or inhibit extraneous 
stimuli. Mukha bhastrika altering afferent inputs from abdominal and thoracic regions, 
in turn modulating activity at ascending reticular activating system and thalamo-cortical 
levels and used as an effective means of improving neuromuscular abilities in special 
children.113 
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4.0 MATERIALS AND METHODS 
4.1 Subjects   
A total of 60 subjects of abdominal obesity of both gender with ages ranging between 
18 – 45 years participated in the study.   
4.1.1 Description of the Subjects Including the Selection of Samples 
The study subjects were conveniently recruited from the Government Yoga & Nature  
Cure Hospital, Arumbakkam, Chennai District of Tamilnadu State in India. The Subjects 
were recruited from the above mentioned hospital through screening done to assess 
diagnostic criteria, inclusion and exclusion criteria. 
Sixty participants were screened through a routine medical check-up and those satisfying 
the Diagnostic criteria for Obesity were recruited for the study (Table 2). 
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4.1.2 Demographics 
Table 2 Demographic details of the subjects 
   Study Group      Control Group 
     Age[Mean ± SD]              32.8±4.56 31.67±2.46 
  Gender distribution 12 Males, 18 Females                   
         (n=30) 
13 Males, 17 Females   
           (n=30) 
Total Participants 
completing the study 
                  30 
 
30 
         Ages range 18 – 45 years 
4.2 Ethical Considerations  
4.2.1 Ethical Clearance  
Ethical clearance was sought from the Institutional Ethics Committee prior to the start 
of the study and the approval for the same was granted.  
4.2.2 Written Informed Consent  
Subjects who fulfilled inclusion criteria were explained about the purpose of the study 
and their rights as research subjects. Informed consent form was administered in English. 
Adequate time was given to each patient to go through the information sheet and their 
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queries were answered. Their right to withdraw anytime from the study and the need for 
willingness to participate voluntarily in the study was explained. All the subjects 
expressed their willingness to participate in the study by giving a signed informed 
consent. 
 
Figure 15: Written consent form 
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4.3 Screening of Subjects  
4.3.1 Criteria for Diagnosis 
4.3.1.a BMI 
Calculation of BMI 
BMI = Body Weight (in kilograms) / Height (in square metre) 
Figure 16 Calculation of Body Mass Index 
4.3.1.b Waist -Hip Ratio 
Calculation of Waist -Hip Ratio = waist (cm) / hip (cm) 
4.3.2 Inclusion and Exclusion Criteria  
4.3.2.1 Inclusion Criteria 
The following inclusion criteria would be the basis for selecting the subjects 
1. Aged between 18-45 years 
2. Both genders 
3. Individuals who can perform pranayama 
4. Obese individuals 
5. No regular physical exercise  
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4.3.2.2 Exclusion Criteria 
Participants will be excluded if they had: 
1. Hormonal Imbalance, any Organic lesions and Metabolic syndromes like 
Hypothyroidism, Hypogonadism, Hypercortisolism, etc. 
2. Nervous system or respiratory ailments, hypertension & diabetes mellitus. 
3. Cardiovascular disease, renal complications, liver disorders and locomotor 
disabilities. 
4. Glaucoma, hernia, or ulcers of the stomach or intestine 
5. Recent abdominal or spinal surgery 
6. Obese female with Pregnancy or Lactation and children 
7. Any type of Addiction like smoking, alcoholism, tobacco chewing, etc 
4.4 Design  
4.4.1 Type of the Design 
A Randomized Controlled Trial with control group 
4.4.1.1 Convenient Sampling 
The patients who satisfied the Inclusion and Exclusion criteria were conveniently 
grouped into Study and Control groups as per the patient availability and period of stay. 
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4.4.1.2 Allocation of patients into study & control groups 
The patients were allocated conveniently to Study group or Control group. 
Sixty subjects were initially screened and assigned to two groups 
i.e., Study group (n=30) and control group (n=30) 
4.5 Data Points 
The data collection was done before (day 1), and after (day 60) the intervention. 
Figure 17: Illustration of Data Points  
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4.4 Trial Profile 
The trail profile of the study is presented as Figure 18 which illustrates the study plan; 
flow of patients across data points and reasons for the drop out.
 
Figure 18: Trail Profile 
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4.6 Assessments  
The baseline and post-intervention assessments consisted of:  
Table 3: List of Primary and Secondary outcome variables 
 
 
 
 
 
 
4.6.1 Primary Outcome Variables 
Body Mass Index (BMI = Weight / Height in sq.meter)  
Waist Circumference &Waist-Hip Ratio (The waist-hip ratio was calculated as the ratio 
of waist and hip circumference). This is calculated as waist measurement divided by hip 
measurement (W ÷ H) 
Abdominal skin fold thickness (To calculate body fat percentage using skin fold calipers. 
 
PRIMARY OUTCOME  
       VARIABLES 
SECONDARY OUTCOME    
         VARIABLES 
Body Mass Index 
Waist-Hip ratio 
Resting Cardio-respiratory 
Parameters 
Abdominal Skin-fold Thickness Pulse rate 
 Respiratory Rate 
 Blood Pressure 
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The body mass index (BMI)  
Height: 
Using standard measuring tape, height in meters or centimetres or inches of each patient 
would be measured. 
Weight: 
Using standard measuring weighing machine KRUPS, ESSAE, EEROKA LTD to 
measure the weight in kilogram or pounds of each patient. 
Waist -Hip Ratio: 
Using the standard measuring tape Waist circumference was measured at the horizontal 
level exactly midway between the costal arch and iliac crest (at the level of umbilicus) 
and hip circumference, the latter was measured at the horizontal level at the place of the 
largest circumference either in the hip or buttock region (above the gluteal sulcus), 
depending on which was larger. The waist-hip ratio was calculated as the ratio of waist 
and hip circumference26. This is calculated as waist measurement divided by hip 
measurement (W ÷ H). For both measurements, the individual should stand with feet 
close together, arms at the side and body weight evenly distributed, and should wear 
little clothing. The subject should be relaxed, and the measurements should be taken at 
the end of a normal respiration. Each measurement should be repeated twice; if the 
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measurements are within 1 cm of one another, the average should be calculated. If the 
difference between the two measurements exceeds 1 cm, the two measurements should 
be repeated. 
Table 4a: Criteria for waist circumference in adults 
 
Table 4b: Criteria for waist/hip ratio in adults 114 
 
 
 
74 
 
 
Figure 19 Picture showing the measurement of Waist-Hip Circumference 
4.6.1.1 Skin-fold Thickness of Abdomen and BMI 
The Skin fold caliper is a device which measures the thickness of a fold of your skin 
with its underlying layer of fat. Landmark a mark is made 5 cm adjacent to the umbilicus 
(belly-button), to the right side. Pinch The vertical pinch is made at the marked site, and 
the calipers placed just below the pinch. Be careful not to place the caliper or fingers 
inside the navel. Do not release the fingers of the left hand while taking the readings. It 
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is important to keep holding firmly the fold of skin with the fingers so that the calipers 
are measuring just the thickness of the fold of skin. You will notice that when you place 
the calipers on the Skin fold that the calipers will "creep" a little, after a few seconds the 
“creep” will slow down and this is the time that the measurement should be taken. You 
must note the reading on the scale before releasing any pressure off the calipers. 
4.6.1.2 Testing Method 
Skin-fold Thickness of Abdomen measuring with the helping caliper. 
 
 
 
Figure 20: Measurement of Skin-fold Thickness using a Caliper 
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4.6.2 Secondary Outcome Variables 
4.6.2.1 Respiratory Rate  
The respiration rate is the number of breaths a person takes per minute. The rate is usually 
measured when a person is at rest and simply involves counting the number of breaths 
for one minute by counting how many times the chest rises. Respiration rates may 
increase with fever, illness, and with other medical conditions. When checking 
respiration, it is important to also note whether a person has any difficulty breathing. 
Normal respiration rates for an adult person at rest range from 12 to 16 breaths per 
minute. 
4.6.2.2 Blood pressure  
Blood pressure was obtained in standard manner by sphygmomanometer. All the reading 
was noted three times with five minutes interval and Mean of all the three values were 
included for the study. 
4.6.2.3 Pulse Rate 
The pulse rate is a measurement of the heart rate, or the number of times the heart beats 
per minute. As the heart pushes blood through the arteries, the arteries expand and 
contract with the flow of the blood. Taking a pulse not only measures the heart rate, but 
also can indicate the following: 
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 Heart rhythm 
 Strength of the pulse 
The normal pulse for healthy adults ranges from 60 to 100 beats per minute. The pulse 
rate may fluctuate and increase with exercise, illness, injury, and emotions. Females ages 
12 and older, in general, tend to have faster heart rates than do males. Athletes, such as 
runners, who do a lot of cardiovascular conditioning, may have heart rates near 40 beats 
per minute and experience no problems. 
4.7 Intervention  
4.7.1   Test Intervention  
The patients in the study group were trained in the proper practice of bastrika Pranayama, 
was made to practice for a period of 60 days twice daily. (Preferably morning or evening)  
4.7.2   Control Intervention 
The control group was under other AYUSH treatments except Yoga for 60 days. They 
were also offered to be trained in the experiment intervention if interested after the study. 
4.8 Data extraction and analysis  
4.8.1 Data Extraction  
The data was collected as self-reported observations using primary outcomes and 
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secondary outcome variables. The assessments were done on the first day (baseline data) 
and end of 60th day (post data). The data was organized in Microsoft Excel Sheets 
(Version 2010).   
4.8.2    Data Analysis  
Data expressed as Mean and SD. Inter group and intra group comparison of mean was 
done by paired and unpaired t test using R statistical software version 3.1.1. 
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                                             5.0 RESULTS 
The present study was conducted to evaluate whether the practice of Bhastrika 
pranayama had any influence in any of the outcome variables viz., Body mass index, 
Skin fold thickness, Pulse rate, Blood Pressure and Waist: Hip Ratio in obese individuals. 
Results were compared within and between groups, wherein data was extracted at both 
baseline and post-intervention. At the beginning of yoga intervention the variables were 
compared in between the groups. 
Table 5 Comparison of variables recorded at the beginning of the yoga program  
 Variables  Yoga group  Control group  P value  
Weight (kg) 84.49±7.90 85.56±10.72 0.12 
BMI  38.52±5.86 37.28±4.87 0.34 
Waist ratio 40.53±3.90 40.90±4.68 0.24 
Hip ratio 42.46±5.70 42.89±7.26 0.34 
W/H ratio 0.98±0.12 0.97±0.32 0.45 
Skin fold thicknes  39.2±3.89 38.67±3.80 0.26 
SBP  118.73±4.26 119.46±6.80 0.11 
DBP 78.13±2.90 82.68±6.87 0.04 
PR  72.87±5.67 71.80±4.60 0.45 
RP 21.56±3.23 20.64±5.60 0.52 
 
80 
 
BMI: Body mass index. 
Table 5 shows the anthropometry parameters in yoga group and control group. In both 
the groups, all the parameters like Weight (84.49 ± 7.90 kg vs 85.56 ± 10.72) and BMI 
(38.52 ± 5.86 kg/m2 vs 37.28 ± 4.87 kg/m2) were not showing a significantly (p > 0.34) 
difference and they were considered for the comparison.  
Table 6 Comparison of variables recorded at the end of the yoga program in between the 
groups 
  Yoga group  Control group  P value  
Weight (kg) 81.26 ± 10.98 84.28±4.67 0.04 
BMI  34.27±3.76 36.78±3.90 0.03 
Waist ratio 38.86±6.90 41.86±5.82 0.05 
Hip ratio 40.49±6.24 41.28±6.40 0.06 
WH ratio 0.93±0.32 0.96±0.13 0.03 
Skin fold thickness  37.86±3.87 37.90±5.60 0.05 
SBP  119.13±5.64 120.86±5.57 0.34 
DBP 72.84±6.12 80.56±7.80 0.01 
PR  70.82±7.18 73.53±5.66 0.05 
RP 19.40±3.98 22.50±8.90 0.07 
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Data Expressed: Mean ± SD. Independent and paired t-test was used to compare the 
intergroup and intra group differences. SBP, Systolic blood pressure; DBP, diastolic 
blood pressure; HR, heart rate; PP, pulse pressure; MAP, mean arterial pressure; RPP, 
rate pressure product; DoP, double product. 
There was no significant difference found in Control group patients. After 60 days of 
intervention, Yoga group patients showed a significant (p < 0.03) reduction in the body 
mass index from 38.52±5.86 to 34.27±3.76 kg/m2, Waist ratio from 40.53±3.90 to 
38.86±6.90, Hip ratio from 42.46±5.70 to 40.49±6.24, Waist/Hip ratio from 0.98±0.12 
to 0.93±0.32, DBP from 78.13±2.90 to 72.84±6.12, RP from 21.56±3.23 to 19.40±3.98 
and PR from 72.87±5.67 to 70.82±7.18. There is no significant difference noticed in skin 
fold thickness from 39.2±3.89 to 37.86±3.87 (p < 0.05) (Table 6).   
Table 7: Comparison of variables after the yoga program in between the yoga and control 
groups 
  Yoga group  P 
value  
Control group  P 
value    Before  After  Before  After  
Age  32.8±4.56 NA 31.67±2.4
6 
 NA 
Height (cm) 152.67 ± 4.80 NA 154.80±6.
90 
 NA 
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Weight (kg) 84.49±7.9
0 
81.26±10.
98 
0.04 85.56±10.
72 
84.28±4.6
7 
0.4 
BMI  38.52±5.8
6 
34.27±3.7
6 
0.03 37.28±4.8
7 
36.78±3.9
0 
0.67 
Waist ratio 40.53±3.9
0 
38.86±6.9
0 
0.05 40.90±4.6
8 
41.86±5.8
2 
0.34 
Hip ratio 42.46±5.7
0 
40.49±6.2
4 
0.06 42.89±7.2
6 
41.28±6.4
0 
0.28 
WH ratio 0.98±0.12 0.93±0.32 0.03 0.97±0.32 0.96±0.13 0.77 
Skin fold 
thickness  
39.2±3.89 37.86±3.8
7 
0.05 38.67±3.8
0 
37.90±5.6
0 
0.24 
SBP  118.73±4.
26 
119.13±5.
64 
0.34 119.46±6.
80 
120.86±5.
57 
0.42 
DBP 78.13±2.9
0 
72.84±6.1
2 
0.02 82.68±6.8
7 
80.56±7.8
0 
0.48 
PR  72.87±5.6
7 
70.82±7.1
8 
0.05 71.80±4.6
0 
73.53±5.6
6 
0.24 
RP 21.56±3.2
3 
19.40±3.9
8 
0.07 20.64±5.6
0 
22.50±8.9
0 
0.43 
 
* compared with after yoga and control. * P<0.05, ** P<0.01, *** P<0.001.  
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Yoga group patients showed a significant (P<0.05) reduction in skin fold thickness after 
60 days of yoga intervention compared to control group patients (P>0.05). In yoga group, 
Waist/Hip ratio was significantly reduced from 0.98±0.12 ms to 0.93±0.32 ms reflecting 
a positive improvement. Skin fold thickness reduced from 39.2±3.89 to 37.86±3.87 in 
yoga group patients after yoga intervention but there was no significant changes (0.05) 
found in control group patients (Table 7). 
6.  DISCUSSION 
The result of this study revealed that practice of Bhastrika Pranayama (NSP) decreased 
the Body mass index and Waist/Hip ratio in the interventional group significantly in 
comparison to that of the control group. In this study, there is a significant difference (p 
within the Study group) in the Weight, Pulse rate, Diastolic Blood Pressure, Body 
Weight, Body Mass Index, Waist circumference, and Hip circumference at the end of 
the 60 days in comparison to their baseline data. However, no significant differences in 
Respiratory Rate, Systolic Blood Pressure, Skin fold thickness, and Hip Ratio were seen 
within this intervention group following the intervention. 
Similar effects noticed in previous studies for example, according to the study conducted 
on the “Effect of Bhastrika Pranayama on waist and hip circumference” in the study 
group, the waist circumference and hip circumference decreased significantly as 
compared to that of control group. This shows that Bhastrika Pranayama has reducing 
impact on waist circumference and hip circumference in overweight individuals17.  
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In a study conducted on “Effect of Bhastrika Pranayamai on selected body composition 
variables” the results showed significant effect on body fat % and no change was found 
in control group19. 
Overall, the practice of Bhastrika pranayama for 60 days among obese individuals has 
resulted in the reduction in weight, waist hip ratio and the body mass index and no 
significant changes noticed in skin-fold thickness. Although Bhastrika pranayama 
improved the quality of living and confidence of the participants. This Yoga practice 
helped to reduce weight. The larger sample size is needed to gain better results.  
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7.0 CONCLUSION 
This study showed that 60 days of Bhastrika Pranayama reduced Body mass index and 
waist hip ratio in obese patients. This revealed that yoga practice has significant role in 
improvement in the weight reduction. Decrease in Weight, Pulse rate, Diastolic Blood 
Pressure, Body Weight, Body Mass Index, Waist circumference, and Hip circumference 
showed that increase in the dominance of parasympathetic activity in Obese patients. 
However, the practice of Bhastrika pranayama showed not much appreciable changes in   
Respiratory Rate, Systolic Blood Pressure, Skin fold thickness, and Hip Ratio in these 
subjects. Further research need in this field with a larger sample size and duration is 
warranted to reveal accurate changes in this field. 
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8.0 SUMMARY 
The aim of this study is to establish the effect of bhastrika pranayama on the abdominal 
obesity. Yoga is the frequently used as a lifestyle intervention to reduce obesity, stress, 
control blood glucose, cholesterol level, control hypertension. In this study, Sixty [male 
or female] patients with Abdominal Obesity of age group between 18-45 years will 
participate the bhastrika pranayama for 10 mins/twice a day for 60 days, under the 
supervision of Department of Yoga and Naturopathy, Government Yoga and 
Naturopathy Medical College, Arumbakkam, Chennai 106. 60 patients separated into 
two groups study group and control group. The assessment variables include pre-
interventional and post-interventional .baseline data was collected on day 1 before 
subjecting the selected subjects into intervention and end point data collected on the day 
60 ie., on the last day of the intervention after the subject finishes their concerned 
intervention. The collected data were properly maintained for the statistical analysis. 
Statistical analysis of the data collected was done by the method of unpaired ‘t’  test. 
Following the analysis of the data, it was shown that there were significant changes in 
the abdominal obesity in the study group. 
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                                          9.0 LIMITATIONS 
1. The sample size is relatively smaller. Hence, generalizing the study outcomes 
to a larger population would not be definitely conclusive. 
2. Duration of the practice is limited; longer exposure to the practice is needed. 
3. Other naturopathic treatments acted as confounding factors during the study. 
9.1 Direction for future research 
1. This study should be replicated with a larger sample size. 
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ANNEXURE 1 
INFORMED CONSENT FORM 
Title of the study: Effect of Bhastrika Pranayama on Abdominal Obesity in Men and 
Women – A Randomized Controlled Trial 
Name of the Participant:  
Name of the Principal Investigator: Dr. A. Jancy Rani 
Name of the Institution: Government Yoga and Naturopathy Medical College, 
Arumbakkam, Chennai – 600 106. 
Documentation of the informed consent 
I _____________________________ have read the information in this form (or it has 
been read to me). I was free to ask any questions and they have been answered. I am over 
18 years of age and, exercising my free power of choice, hereby give my consent to be 
included as a participant in “Effect of Bhastrika Pranayama on Abdominal Obesity in 
Men and Women – A Randomized Controlled Trial” 
1. I have read and understood this consent form and the information provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the investigator. 
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5. I have been informed the investigator of all the treatments I am taking or have taken 
in the past ________ months including any native (alternative) treatment. 
6. I have been advised about the risks associated with my participation in this study. 
7. I agree to cooperate with the investigator and I will inform him/her immediately if I 
suffer unusual symptoms.  
8. I have not participated in any research study within the past ________month(s).  
9. I am aware of the fact that I can opt out of the study at any time without having to give 
any reason and this will not affect my future treatment in this hospital.  
10. I am also aware that the investigator may terminate my participation in the study at 
any time, for any reason, without my consent.  
12. I hereby give permission to the investigators to release the information obtained from 
me as result of participation in this study to the sponsors, regulatory authorities, Govt. 
agencies, and IEC. I understand that they are publicly presented. 
13. I have understood that my identity will be kept confidential if my data are publicly 
presented. 
14. I have had my questions answered to my satisfaction. 
15. I have decided to be in the research study. 
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I am aware that if I have any question during this study, I should contact the investigator. 
By signing this consent form I attest that the information given in this document has been 
clearly explained to me and understood by me, I will be given a copy of this consent 
document. 
For adult participants: 
Name and signature / thumb impression of the participant (or legal representative 
if participant incompetent) 
Name_________________________  Signature_________________  
Date________________ 
Name and Signature of impartial witness (required for illiterate patients): 
Name _________________________ Signature_________________  
Date _________________ 
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INFORMATION TO PARTICIPANTS 
Investigator:                  Dr. A. Jancy Rani, B.N.Y.S 
Name of Participant: 
Title: Effect of Bhastrika Pranayama on Abdominal Obesity in Men & Women – A 
Randomized Controlled Trial 
You are invited to take part in this research/ study /procedures. The information in this 
document is meant to help you decide whether or not to take part. Please feel free to ask 
if you have any queries or concerns. You are being asked to participate in this study 
being conducted in Government Yoga and Naturopathy Medical College, Arumbakkam, 
Chennai – 600 106. 
The purpose of the research study is to determine the Effect of Bhastrika Pranayama on 
Abdominal Obesity in Men & Women – A Randomized Controlled Trial.  
Study Procedures 
The study involves assessment of Motor Nerve Conduction Velocity. 
You will be required to visit the hospital during the study. 
(The test involves Electro Myogram / EMG study before the commencement of therapies 
and after 56 days.) 
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You may have to come to the hospital (study site) for examination and investigations 
apart from your scheduled visits, if required. 
Possible Risks to you - Nil 
Possible benefits to you- NIl. 
Possible benefits to other people 
The result of the research may provide benefits to the society in terms of advancement 
of medical knowledge and/or therapeutic benefits to future patients. 
Confidentiality of the information obtained from you 
You have the right to confidentiality regarding the privacy of your medical information 
(personal details, results of physical examinations, investigations, and your medical 
history). By signing this document, you will be allowing the research team investigators, 
other study personnel, sponsors, IEC and any person or agency required by law like the 
Drug Controller General of India to view your data, if required. 
The information from this study, if published in scientific journals or presented at 
scientific meetings, will not reveal your identity. 
How will your decision to not participate in the study affect you? 
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Your decisions to not to participate in this research study will not affect your medical 
care or your relationship with investigator or the institution. Your doctor will still take 
care of you and you will not lose any benefits to which you are entitled. 
Can you decide to stop participating in the study once you start? 
The participation in this research is purely voluntary and you have the right to withdraw 
from this study at any time during course of the study without giving any reasons. 
However, it is advisable that you talk to the research team prior to stopping the treatment. 
 
Signature of investigator      Signature of participant 
Date 
 
 
 
 
 
 
